WILLIAM ABROKWA: Open Payments
NPI 1205346335 · SOUTH WINDSOR, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$223 in 12 payments from 9 companies in 2025. Trend: 2023 $70 · 2024 $136 · 2025 $223
Food & beverage: $223
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $57 |
| Alkermes, Inc. | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Corium, LLC | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $14 |
Products named: CAPLYTA, ARISTADA, REXULTI, COBENFY, Azstarys, Qelbree, VRAYLAR, INGREZZA.
Industry payments across CT — which companies pay providers there.
